Conference - Events

The 2nd LNP Immunogenicity and Toxicity Summit is set to unite 100+ PKPD, Immunology, Safety, Toxicology experts from biopharma and academia. This is your opportunity to join key opinion leaders within the industry to explore the steep progress being made in the space and actively address the field's most pressing challenges through multiple deep-dive discussions. In collaboration with Pfizer, BioNTech, Sanofi and Eli Lilly, this 3-day summit will bring together senior leaders dedicated to understanding and predicting the next wave of LNP's immunogenicity and toxicity challenges, to support drug developers to ensure smooth filing with long-term patient safety in mind. This year we are moving alongside the pharmaceutical industry and bringing the focus to accurately measuring immuno-tox of…

The field of targeted covalent therapeutics is seeing a surge of activity, with both new and established companies investing heavily in the space. The inaugural Covalent Drug Discovery Summit has been built alongside industry experts to provide a dedicated forum to tackle associated challenges and advance covalent therapeutics; previously only afforded a small feature in larger 'small molecule' conferences. As the very first meeting solely focused on covalent therapeutics, the 18+ speaker faculty boasts leaders from large pharma, new biotech and academia. This is the summit to meet 80+ covalency experts gathering to solve target selectivity, hit screening, lead optimization, and covalent warhead design to carve out covalency's niche for targeting the "undruggable" proteome.

Join us at the Digital Health Partnering Summit, Where we bring Together Industry-leading Dealmakers, Innovators, Investors & Decision-makers from the Pharma Biotech Sector. This Exclusive Event is Dedicated to Exploring the Latest Advancements in Digital Health Therapies &Technologies. Creating a Dynamic Platform for Collaboration, Business Opportunities, & Fostering Innovation. Expand your Knowledge and Gain valuable Insights into the Rapidly Evolving Digital Health Landscape. Our Agenda Features Engaging Keynote Presentations, Thought-provoking Panel Discussions, Interactive Breakout Sessions, and Dedicated Networking Opportunities. You'll stay at the Forefront of the Latest Trends and Innovations, and Delve into Discussions Surrounding the Challenges and Opportunities that…

2023 has seen advances in artificial intelligence, screening tools and progression into the clinic coupled with numerous strategic collaborations and investments into early discovery has re-fuelled the need to discover selective small molecules to drive drug development forward. In this context, the RNA Targeted Drug Discovery and Development Summit returns for its 6th year as the most comprehensive, end-to-end meeting, uniting 200+ RNA targeting experts to explore how the latest technologies are improving target validation to fast-track lead optimization and overcoming species difference challenges so more safe and effective drugs can advance into the clinic.   Time: 8:15 AM - 4:15 PM

Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy. In the past 3 months alone, we have witnessed 20 new drugs entering into pre-clinical and clinical phases, and exciting FDA Fast Track Designation for Candel Therapeutics OV candidate - this community continues to maximize the impact of these hopeful therapies. Unite with 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing and Control…

Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has never been a greater priority for this community. The first Gene Therapy Process Development is your only specific gene therapy event with optimizing process development with the transgene at the forefront of mind. Join your biopharma colleagues from the likes of Ultragenyx, Janssen, REGENXBIO and more, for two days of cutting-edge talks on cell-line development, scale-up, transfection, purification, analytics, and regulation. This must-attend meeting is your chance to share ideas, successes, and challenges, and capitalize on the latest advances in process development to bring safe and effective drug…

Following proof of concept in oncology, misfolded and aggregated pathological proteins across CNS indications are the new frontier for protein degradation technologies. Heading to Boston, the Targeted Protein Degradation for CNS Summit is uniting 50+ experts with 3-days of industry-focused content solely dedicated to delivering and translating TPD technologies to degrade undruggable extracellular and intracellular CNS proteins. Don't miss your chance to join industry leaders pioneering the exploration of PROTACs, AUTOTACs, molecular glues, and more revolutionary TPD technologies against CNS targets. This is your only chance to attend an industry-focused meeting dedicated to showcasing early CNS biopharma investment and overcoming your challenges to translate safe and efficacious protein de…

The marcus evans 24th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 17-19 January, 2024, in Frankfurt, Germany, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing  the  best  methodologies, technologies, and organizational models. The event will explore how you can maximize the value  and  resilience  of  your  portfolio  through the  best  practices  in  project prioritization  and  resource  allocation, focusing  on  creating  the  ideal  balance  between  risks  and  opportunities. All these topics and more will be discu…

5th Edition Excellence in Real World Evidence and Data Utilization January 23- 24, 2024Philadelphia, PA The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data. Key Speakers Include Charles MakinGlobal Head, HEOR, HTA & RWEBiogen Amit KulkarniHead of Health Economic Modeling a…

With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important. As the first ever regulatory affairs forum wholly dedicated to gene therapy, this meeting uniquely unites regulatory bodies and the leading regulatory personnel across big pharma and innovative biotech to discuss the hottest topics, identify industry bottlenecks and offer actionable insights. Don't miss out on this unrivalled opportunity to inform your trial design, perfect your CMC approach and supercharge your global submission strategy for regulatory success. Join 80+ industry leaders from 4D Molecular T…

The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe's largest and most important gathering of mRNA experts. Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 250+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R and D and pipeline expansions. URLs:Tickets: https://go.evvnt.com/1951095-2?pid=185Brochure: https://go.evvnt.com/1951095-3?pid=185 Prices:Conference + Focus Day OR Workshop Day - Drug Developer Pricing: EUR 4446.00,Conference Only - Drug Developer Pricing:…

The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs. In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts. The C…

This premier marcus evans conference explores future regulation implications on post market management planning, risk management, complaint handling and clinical evaluations to align with revised and ever changing EU MDR deliverables. Moreover attendees will be provide a blueprint on how to develop innovative PMCF, PSUR, safety, quality, adverse event and post market reporting document processes.

Advance Scalability, Accessibility and Affordability of Autologous Cell Therapies As the cell therapy space bears witness to an increasing number of autologous therapies gaining regulatory approval, the essential role of the manufacturing ecosystem has never been clearer. It is business critical for cell therapy drug developers to have a robust strategy for scale up whilst overcoming the labour and cost intensive nature of batch manufacturing to reduce the cost of goods. Enter the timely arrival of the inaugural Decentralized Manufacturing for Cell Therapy Summit, the pioneering forum for cell therapy leaders across manufacturing to gain practical insights into the strategic adoption of decentralized manufactured cell therapy products in order to reduce manufacturing turnaround time and ov…

Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inflection point in drug discovery thanks to the increase in collaboration between AI tech development and big pharma. This is evidenced by third-party investment in AI-enabled drug discovery more than doubling annually for the last five years. With ongoing headlines spotlighting GSK, AZ, Novartis, Roche, Bayer, and Sanofi's positive results from their AI-powered drug discovery efforts, industry is teetering on the precipice of a breakthrough and the time to get involved is now! Uniting computational and analytics experts to successfully capitalize on the transformative power of AI, the Practical AI for Drug Discovery and Preclinical Development Sum…

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the field caused by the FDA Modernization Act 2.0, 2023 has set an exciting precedent for the upcoming year. However, the translation rates of oncology therapeutics into the clinic remain at 20%, proving there remains a large unmet need for tools to support drug development efforts in a patient-specific context at the preclinical and early translational levels. At the 8th Annual Tumor Models San Francisco Summit, you will gain practical insights into the latest updates across the West Coast and beyond through 25+ case studies that will empower your candidate selection workflows. Join us to learn from an…

We are delighted to welcome you to the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2024) to be held on 6-9 March 2024 in Florence, Italy. We invite you to be a part of ATTD – the leading international forum – where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with diabetes, assemble with the goal to ameliorate the care of people with diabetes as the fastest possible pace. Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as artificial intelligence-based decision support systems, glucose sensors, closed-loop systems, artificial pancreas, devices for diabetic prevention, new medications for…

The Annual Pharma Supply Chain & Security World Summit is back in London for the 6th time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance wit…

Welcome to the International Cancer Research and Drug Discovery Conference (i-Cancer Congress), in London on March 22, 2024. We're excited to bring together healthcare professionals from around the world to discuss the latest developments and innovations. i-Cancer Congress is designed to provide a platform for experts in the field of oncology to share their knowledge, exchange ideas, and collaborate on new research projects. The conference will cover a wide range of topics related to cancer research, diagnosis, treatment, and prevention. With a range of presentations, workshops, and networking opportunities, attendees will have the chance to learn from some of the most accomplished healthcare professionals in the world. In addition to learning from expert speakers, attendees will also have…

This conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. Additionally, this meeting also showcases ground-breaking research being performed by leadings scientist from around the globe. Attendees will have the opportunity to hear the leading companies and academics discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes. Prices:Industry: USD 1595.00,Academic/Government/Clinician: USD 695.00,Student: USD 450.00 Time: 8:00 am to 3:00 pm